高级搜索
长春瑞滨联合异环磷酰胺治疗晚期非小细胞肺癌的临床研究[J]. 肿瘤防治研究, 2002, 29(03): 241-242. DOI: 10.3971/j.issn.1000-8578.3085
引用本文: 长春瑞滨联合异环磷酰胺治疗晚期非小细胞肺癌的临床研究[J]. 肿瘤防治研究, 2002, 29(03): 241-242. DOI: 10.3971/j.issn.1000-8578.3085
The clinical study of combination chemotherapy with navelbine and ifosfamide in treating of advanced Non-small cell lung cancer[J]. Cancer Research on Prevention and Treatment, 2002, 29(03): 241-242. DOI: 10.3971/j.issn.1000-8578.3085
Citation: The clinical study of combination chemotherapy with navelbine and ifosfamide in treating of advanced Non-small cell lung cancer[J]. Cancer Research on Prevention and Treatment, 2002, 29(03): 241-242. DOI: 10.3971/j.issn.1000-8578.3085

长春瑞滨联合异环磷酰胺治疗晚期非小细胞肺癌的临床研究

The clinical study of combination chemotherapy with navelbine and ifosfamide in treating of advanced Non-small cell lung cancer

  • 摘要: 目的 探讨长春瑞滨加异环磷酰胺方案对Ⅲb Ⅳ期NSCIC的疗效。方法 本研究应用长春瑞滨加异环磷酰胺治疗Ⅲb Ⅳ期非小细胞肺癌 37例。结果 取得CR 3例、PR 15例, 总有效率 4 8.6 %, 初治者有效率 5 0 %, 复治者有效率 4 2 .9%, 主要毒性反应为白细胞减少, 发生率为 83.6 %。结论 研究表明本方案疗效明确, 耐受性好。

     

    Abstract: Objective To study the effect of combination chemotherapy of Navelbine and Ifosfamide in the treatment of stage Ⅲ b -Ⅳ non-small cell lung cancer. Methods Thirty-seven patients with stageⅢ b -Ⅳ non-small cell lung cancer were treated with Navelbine and Ifosfamide . Results Complete response in 3 patients and partial response in 15 were observed with an overall response rate of 48.6%. Leukopenia was the most frequent toxicity(83.6%) . Conclusion The study demonstrated that this regimen is effe...

     

/

返回文章
返回